Will stock surge before Earnings results? NASDAQ:CTRN, NYSE:MOD, NASDAQ:PRVA, NASDAQ:PALI

CITI TRENDS (NASDAQ:CTRN) EARNINGS INFORMATION (NASDAQ:CTRN)

Citi Trends last posted its quarterly earnings results on May 24th, 2021. The reported $3.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.90 by $0.33. Citi Trends has generated $2.38 earnings per share over the last year and currently has a price-to-earnings ratio of 11.0. Citi Trends has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, August 19th, 2021 based off prior year’s report dates.

IS CITI TRENDS A BUY RIGHT NOW? (NASDAQ:CTRN)

1 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Citi Trends in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Citi Trends stock.
Citi Trends

MODINE MANUFACTURING (NYSE:MOD) EARNINGS INFORMATION (NYSE:MOD)

Modine Manufacturing last announced its earnings data on May 25th, 2021. The auto parts company reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.24. Modine Manufacturing has generated $1.14 earnings per share over the last year. Modine Manufacturing has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, August 3rd, 2021 based off prior year’s report dates.

IS MODINE MANUFACTURING A BUY RIGHT NOW? (NYSE:MOD)

3 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Modine Manufacturing in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Modine Manufacturing stock.
Modine Manufacturing

(NASDAQ:PRVA)

IS PRIVIA HEALTH GROUP A BUY RIGHT NOW? (NASDAQ:PRVA)

7 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Privia Health Group in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Privia Health Group stock.
Privia Health Group

(NASDAQ:PALI)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN PALISADE BIO? (NASDAQ:PALI)

Wall Street analysts have given Palisade Bio a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Palisade Bio wasn’t one of them. MarketBeat thinks these five companies may be even better buys.